Literature DB >> 21948365

Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.

Brandon L Garcia1, Kasra X Ramyar, Daniel Ricklin, John D Lambris, Brian V Geisbrecht.   

Abstract

Our understanding of both the nature and diversity of Staphylococcal immune evasion proteins has increased tremendously throughout the last several years. Among this group of molecules, members of the SCIN and Efb families of complement inhibitors have been the subject of particularly intense study. This work has demonstrated that both types of proteins exert their primary function by inhibiting C3 convertases, which lie at the heart of the complement-mediated immune response. Despite this similarity, however, significant differences in structure/function relationships and mechanisms of action exist between these bacterial proteins. Furthermore, divergent secondary effects on host immune responses have also been described for these two protein families. This chapter summarizes recent advances toward understanding the structure, function, and mechanism of the SCIN and Efb families, and suggests potential directions for the field over the coming years.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21948365      PMCID: PMC3422867          DOI: 10.1007/978-1-4614-0106-3_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  64 in total

1.  Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).

Authors:  L Clemenza; D E Isenman
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

2.  Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the alpha-chain.

Authors:  M Palma; O Shannon; H C Quezada; A Berg; J I Flock
Journal:  J Biol Chem       Date:  2001-06-20       Impact factor: 5.157

3.  A structural basis for complement inhibition by Staphylococcus aureus.

Authors:  Michal Hammel; Georgia Sfyroera; Daniel Ricklin; Paola Magotti; John D Lambris; Brian V Geisbrecht
Journal:  Nat Immunol       Date:  2007-03-11       Impact factor: 25.606

Review 4.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

Review 5.  Complement driven by conformational changes.

Authors:  Piet Gros; Fin J Milder; Bert J C Janssen
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

Review 6.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

7.  Staphylococcal complement inhibitor: structure and active sites.

Authors:  Suzan H M Rooijakkers; Fin J Milder; Bart W Bardoel; Maartje Ruyken; Jos A G van Strijp; Piet Gros
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

8.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

9.  Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus.

Authors:  Michal Hammel; Georgia Sfyroera; Serapion Pyrpassopoulos; Daniel Ricklin; Kasra X Ramyar; Mihai Pop; Zhongmin Jin; John D Lambris; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

10.  Staphylococcal complement evasion by various convertase-blocking molecules.

Authors:  Ilse Jongerius; Jörg Köhl; Manoj K Pandey; Maartje Ruyken; Kok P M van Kessel; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  19 in total

Review 1.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

2.  A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.

Authors:  Brandon L Garcia; Brady J Summers; Kasra X Ramyar; Apostolia Tzekou; Zhuoer Lin; Daniel Ricklin; John D Lambris; John H Laity; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

3.  The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.

Authors:  Jordan L Woehl; Daphne A C Stapels; Brandon L Garcia; Kasra X Ramyar; Andrew Keightley; Maartje Ruyken; Maria Syriga; Georgia Sfyroera; Alexander B Weber; Michal Zolkiewski; Daniel Ricklin; John D Lambris; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Immunol       Date:  2014-11-07       Impact factor: 5.422

4.  Identification of C3b-Binding Small-Molecule Complement Inhibitors Using Cheminformatics.

Authors:  Brandon L Garcia; D Andrew Skaff; Arindam Chatterjee; Anders Hanning; John K Walker; Gerald J Wyckoff; Brian V Geisbrecht
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

Review 5.  Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis.

Authors:  Gowrishankar Muthukrishnan; Elysia A Masters; John L Daiss; Edward M Schwarz
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

6.  Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.

Authors:  Brady J Summers; Brandon L Garcia; Jordan L Woehl; Kasra X Ramyar; Xiaolan Yao; Brian V Geisbrecht
Journal:  Mol Immunol       Date:  2015-06-04       Impact factor: 4.407

7.  The structural basis for inhibition of the classical and lectin complement pathways by S. aureus extracellular adherence protein.

Authors:  Jordan L Woehl; Kasra X Ramyar; Benjamin B Katz; John K Walker; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2017-05-31       Impact factor: 6.725

Review 8.  Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.

Authors:  Daniel Ricklin
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

9.  Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb.

Authors:  Maria Georgoutsou-Spyridonos; Daniel Ricklin; Haris Pratsinis; Eustathia Perivolioti; Ioannis Pirmettis; Brandon L Garcia; Brian V Geisbrecht; Periklis G Foukas; John D Lambris; Dimitrios C Mastellos; Georgia Sfyroera
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

Review 10.  Novel Evasion Mechanisms of the Classical Complement Pathway.

Authors:  Brandon L Garcia; Seline A Zwarthoff; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Immunol       Date:  2016-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.